Welcome to our dedicated page for AVIENT SEC filings (Ticker: AVNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AVIENT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AVIENT's regulatory disclosures and financial reporting.
Avient Corporation (AVNT) has filed a Form 4 indicating that director Robert E. Abernathy acquired 1,187 shares of common stock on 30 June 2025 at an effective price of $0, implying the shares were granted rather than purchased on the open market. After the award, Abernathy directly owns 37,368 shares, a rise of roughly 3 % compared with his prior holding.
No sales, option exercises, or derivative transactions were reported, and Table II shows no positions in warrants, options, or other convertible securities. The filing is routine, modest in size relative to Avient’s float, but it slightly increases insider equity alignment.